The LIGHT Consortium

Men continue to experience more than twice the prevalence of TB than women across LMICs. This LIGHT Consortium-supported systematic review and meta-analysis adds to the evidence for gender-responsive TB prevention, diagnosis, and care. 📖 journals.plos.org/plosmedicine... #TB #EndTB #GlobalHealth

Who is most likely to miss out on TB diagnosis and treatment? This LIGHT impact case study shows how better data uncovered important differences between men, women & young people helping shape fairer TB policies, strengthen national reporting & improve care. Read: light.lstmed.ac.uk/resources/li...

🎥Real stories from the LIGHT Consortium. This video captures moments of growth, connection, and collaboration from across our journey. Each voice tells part of a bigger story. youtu.be/uPvT-NF1EX8?... 📖 Read the full reflections: light.lstmed.ac.uk/sites/defaul... #GlobalHealth #Collaboration

We cannot #EndTB with inequitable partnerships. LIGHT shows shared leadership & inclusive governance lead to stronger TB research and impact. How we work matters. Build equitable, locally led partnerships. Read the case study: light.lstmed.ac.uk/sites/defaul...

We cannot #EndTB if evidence isn’t used. LIGHT strengthened capacity so researchers, policymakers & media can turn TB evidence into action. It’s not just about generating data—it’s about using it. Invest in capacity. Read the case study: light.lstmed.ac.uk/sites/defaul...

We cannot #EndTB without political will, accountability & financing. LIGHT brought TB evidence into parliaments & decision-making spaces—driving action on gender disparities & funding. TB is not just a health issue—it’s political. Read the case study: light.lstmed.ac.uk/sites/defaul...

We cannot #EndTB without turning evidence into policy. Gender barriers in TB are recognised—but too often not acted on. LIGHT supported countries to strengthen gender-responsive TB policies & guidelines. From evidence to action. Read more: light.lstmed.ac.uk/sites/defaul...

We cannot #EndTB without communities at the centre. LIGHT research in Nigeria & Uganda shows community-led TB solutions work—reducing stigma & increasing TB notifications by 35%. People with lived experience are not beneficiaries—they are partners. Read more: light.lstmed.ac.uk/sites/defaul...

We cannot #EndTB without reaching the “missing men.” LIGHT research in Uganda & Kenya shows TB services often fail to reflect men’s realities. Gender-responsive solutions led to a 51% increase in TB notifications. Design services that work for men. Act: light.lstmed.ac.uk/sites/defaul...

We won’t #EndTB if young people are left behind. LIGHT research shows adolescents & young adults face major barriers to TB care in Malawi & Kenya. We need youth-friendly, gender-responsive services—and young people as partners in designing them. Act: light.lstmed.ac.uk/sites/defaul...

New evidence is shaping TB policy and care in Uganda 🇺🇬 Through LIGHT, researchers at Gombe and Mityana Hospitals tested gender-responsive TB screening to improve diagnosis and care for men. 📄 Read the evidence brief: mli.mak.ac.ug/light-eviden... 🎥 Watch the Uganda video: youtu.be/BuM0MVoQnoQ?...

Impact. Partnership. Legacy. The LIGHT Consortium in Malawi has strengthened TB responses through research, collaboration, and evidence-informed action. Watch how the programme has transformed lives and systems here: www.youtube.com/watch?v=t8nR...

Nigeria remains one of the highest TB burden countries but our research is driving change through: 🔹 Men-focused TB interventions 🔹 Reduced stigma 🔹 Community-led solutions 🔹 Evidence shaping policy Ending TB needs partnership & local leadership 🎥Watch: youtu.be/_Fvb5Fw_OLM?... @zanklic.bsky.social

Building stronger health systems through evidence and collaboration. The LIGHT Consortium partners in #Kenya has helped to improve TB responses and create lasting impact through research and partnerships in Kenya Watch the story here: www.youtube.com/watch?v=rxp4... @afidep.bsky.social

TB is preventable and curable - yet millions are still affected every year. The problem isn’t just medical. It’s social, structural, and gendered. This video shows how LIGHT is working with communities to change that. 🎥 Watch here: youtu.be/aaHVqoMTw2E?... #EndTB #GlobalHealth #HealthEquity

What does it take to make tuberculosis care truly equitable? This webinar shares lessons from a 6-year programme across Nigeria, Uganda, Kenya, and Malawi—showing how gender-responsive, community-led approaches can improve TB outcomes and influence policy. Watch: youtu.be/e1NUVIA_ghA?...

Why are men more affected by TB in Malawi? Higher exposure starts in adolescence-linked to smoking, alcohol use & high-risk environments. Good news:mobile, community TB testing is reaching more men & connecting them to care. Tackling TB in men protects whole communities: youtu.be/wMP4f05lgHM?...

🚨Research only matters if it’s used. Turn evidence into action with the Toolkit for Research Uptake—practical tools for real-world impact. Grounded in first-hand experience from the LIGHT Research Programme. It's practical, adaptable, & ready to use. light.lstmed.ac.uk/learning/res...

Great to see this work led by @alexandra-richards.bsky.social with @lightontb.bsky.social in @commsmed.nature.com. Further evidence that addressing gender disparities in TB burden and care are necessary for both an equitable response *and* an effective response. ⬇️

What if targeting TB in men could benefit entire populations? This new modelling study from @alexandra-richards.bsky.social suggests exactly that 👇 ✔️ More treatment coverage ✔️ Address social & structural risks 👉 Big reductions in TB incidence & mortality 🔗 www.nature.com/articles/s43...

In commemoration of #WorldTBDay, we started with a road walk to sensitize the community on TB and the importance of early diagnosis & treatment. 🚶🏽‍♀️🚶🏾‍♂️ Then, @lightontb.bsky.social and @zanklic.bsky.social hosted a scientific symposium with the theme: #EndTB #GenderAndTB #LightConsortium

Join TODAY online ⤵️

LIGHT shares findings from a 6-year TB programme in Uganda led by @maklunginstitute.bsky.social calling for gender-responsive, people-centred care. NTLP testimonies show stronger capacity, with data shaping policy and survivor-led Photovoice transforming TB programmes.

Dr Obioma Chijioke-Akaniro launches the Inspirational Women Seminar Series at LSTM with “I Dare to Try,” sharing her journey in medicine, leadership & advocacy. 📅 1 Apr 2026 ⏰ 11:30–12:30 BST 📍 Liverpool + online 🎟️ www.tickettailor.com/events/liver... #GlobalHealth #WomenInScience

Young people are a key group in the fight against TB. In Kenya, ages 15–24 account for 20% of TB patients lost to follow-up. Research from Nairobi County explores why and how youth-friendly TB services could improve care. 🎥 Watch Rhoda Pola share the findings: www.youtube.com/watch?v=5sgA...

Join us for the closing webinar of the LIGHT research programme exploring gender-responsive approaches to TB care. 📅 31 March 2026 |⏰ 12:00–13:30 BST Hear key findings from 6 years of global research, community-led insights, and what’s next for scaling impact. 👉 Register: shorturl.at/QVLDX

CALL FOR ABSTRACTS 📣 @ReSoKenya & @Afidep join stakeholders to organise the 7th Kenya International Scientific Lung Health Conference. Work in TB, lung health or health systems? 📍 5–8 Aug 2026 📌 Mombasa ⏳ 31 Mar 2026 📩 Submit your abstract: www.resok.org/kislhc/abstr...

Season’s Greetings from the LIGHT Consortium 🌟 We’re grateful to everyone who has contributed to our work this year—partners, collaborators, and the wider community. Here’s to reflection, rest, and renewed energy for the year ahead. Warm wishes for the festive season!

@bnmtnepal.bsky.social team talking to Beate Ringwald about how to implement participatory co-design approaches with our communities. #UnionConf @lightontb.bsky.social

👩🏾‍⚕️ Do young men and women face different TB mortality risks? Today: Rhoda Pola (Nairobi, Kenya) presents at #WCLH2025: Gender-specific predictors of TB mortality among adolescents & young adults in Kenya. Findings highlight gendered vulnerabilities & opportunities for targeted TB interventions.